Roche Holding AG
Închisă
SectorSănătate
373.2 0.92
Rezumat
Modificarea prețului
24h
Minim
373.2
Maxim
374.6
Venit | 1.4B 6.9B |
|---|---|
Vânzări | -208M 30B |
P/E Medie Sector | 23.632 68.51 |
Randament dividend | 2.72 |
Marjă de profit | 22.629 |
Angajați | 103,249 |
EBITDA | -2.2B 9.4B |
Randament dividend Medie Sector | 2.72% 2.29% |
|---|
Capitalizare de piață | 22B 288B |
|---|---|
Deschiderea anterioară | 372.28 |
Închiderea anterioară | 373.2 |
Roche Holding AG Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Știri relevante
Comparație
Modificare preț
Roche Holding AG Așteptări
Date financiare
Cheltuieli de vânzare și administrare
Cheltuieli de exploatare
Profit pre-impozitare
Vânzări
Costul vânzărilor
Profit brut din vânzări
Cheltuieli cu dobânzile pe datorie
EBITDA
Profit operațional
$
Despre Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.